1. Histone 3 lysine 9 acetylation-specific reprogramming regulates esophageal squamous cell carcinoma progression and metastasis
   Zhenhui Chen et al, 2024, Cancer Gene Therapy CrossRef
2. Genetic and molecular bases of esophageal Cancer among Iranians: an update
   Mohammad Reza Abbaszadegan et al, 2019, Diagnostic Pathology CrossRef
3. Tumoral Expression of CD166 in Human Esophageal Squamous Cell Carcinoma: Implications for Cancer Progression and Prognosis
   Xiaoshan Zhang et al, 2020, Cancer Biotherapy and Radiopharmaceuticals CrossRef
4. Molecular subclassification of gastrointestinal cancers based on cancer stem cell traits
   Mei-Mei Li et al, 2021, Experimental Hematology & Oncology CrossRef
5. MSI1 Stabilizes MACF1 to Inhibit Apoptosis of MC3T3-E1 Cells Induced by High Glucose and Promote Osteogenic Differentiation Through Wnt/β-Catenin Signaling Pathway
   Li Zou et al, 2023, Molecular Biotechnology CrossRef
6. Potential markers of cancer stem-like cells in ESCC: a review of the current knowledge
   Lu Wang et al, 2024, Frontiers in Oncology CrossRef
7. Knockdown of MSI1 inhibits the proliferation of human oral squamous cell carcinoma by inactivating STAT3 signaling
   Chen‑Fei Wang et al, 2019, International Journal of Molecular Medicine CrossRef
8. Musashi–1—A Stemness RBP for Cancer Therapy?
   Nadine Bley et al, 2021, Biology CrossRef
9. Targeting Liver Cancer Stem Cells: An Alternative Therapeutic Approach for Liver Cancer
   Hwa-Yong Lee et al, 2020, Cancers CrossRef